{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:36:57Z","timestamp":1790401017088,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.euroneuro.2005.04.016","type":"journal-article","created":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T17:05:56Z","timestamp":1118336756000},"page":"1-6","source":"Crossref","is-referenced-by-count":25,"title":["The serotonin-1D\u03b2 receptor gene and severity of obsessive-compulsive disorder in women with bulimia nervosa"],"prefix":"10.1016","volume":"16","author":[{"given":"R.D.","family":"Levitan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Masellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.S.","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.euroneuro.2005.04.016_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/comp.2001.27903","article-title":"Bulimia nervosa with and without obsessive-compulsive syndromes","volume":"42","author":"Albert","year":"2001","journal-title":"Compr. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2005.04.016_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1176\/appi.ajp.160.2.242","article-title":"Childhood obsessive-compulsive personality traits in adult women with eating disorders: defining a broader eating disorder phenotype","volume":"160","author":"Anderluh","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2005.04.016_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1176\/appi.ajp.158.4.563","article-title":"Morbidity risk for obsessive-compulsive spectrum disorders in first-degree relatives of patients with eating disorders","volume":"158","author":"Bellodi","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.04.016_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0006-3223(00)00831-3","article-title":"The relationship of obsessive-compulsive disorder to possible spectrum disorder: results from a family study","volume":"48","author":"Bienvenu","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.04.016_bib5","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archpsyc.1992.01820110016002","article-title":"Neuroendocrine responses to m-chlorophenyl-piperazine and l-tryptophan in bulimia","volume":"49","author":"Brewerton","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2005.04.016_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0010-440X(92)90051-Q","article-title":"Comparative psychopathology of women with bulimia nervosa and obsessive-compulsive disorder","volume":"33","author":"Bulik","year":"1992","journal-title":"Compr. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2005.04.016_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S1461145703003869","article-title":"A family-based association study of the 5-HT-1 Dbeta receptor gene in obsessive compulsive disorder","volume":"7","author":"Camarena","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2005.04.016_bib8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/1096-8628(20000612)96:3<384::AID-AJMG28>3.0.CO;2-P","article-title":"Complex segregation analysis of obsessive-compulsive disorder in 141 families of eating disorder probands, with and without obsessive-compulsive disorder","volume":"96","author":"Cavallini","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"10","key":"10.1016\/j.euroneuro.2005.04.016_bib9","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1176\/appi.ajp.159.10.1783","article-title":"No association between obsessive-compulsive disorder and the 5-HT(1Dbeta) receptor gene","volume":"159","author":"Di Bella","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.04.016_bib10","series-title":"Structured Interview for DSM-IV Axis-1 Disorders-Patient Edition, Version 2","author":"First","year":"1995"},{"key":"10.1016\/j.euroneuro.2005.04.016_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1992.01820020059008","article-title":"Fluoxetine in the treatment of bulimia nervosa","volume":"49","author":"Fluoxetine Bulimia Nervosa Collaborative Study Group","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2005.04.016_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0006-3223(94)00235-U","article-title":"m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation","volume":"38","author":"Goodman","year":"1995","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2005.04.016_bib13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1034\/j.1600-0447.2000.102006449.x","article-title":"Symptoms of eating disorders in obsessive-compulsive disorder","volume":"102","author":"Grabe","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.euroneuro.2005.04.016_bib14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s004060070017","article-title":"Prevalence, quality of life and psychosocial function in obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in northern Germany","volume":"250","author":"Grabe","year":"2000","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"Suppl. 35","key":"10.1016\/j.euroneuro.2005.04.016_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1192\/S0007125000297912","article-title":"Pharmacotherapy for obsessive-compulsive disorder","volume":"173","author":"Greist","year":"1998","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2005.04.016_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0924-977X(02)00129-3","article-title":"Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder","volume":"13","author":"Hemmings","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Suppl. 8","key":"10.1016\/j.euroneuro.2005.04.016_bib17","first-page":"3","article-title":"Obsessive-compulsive and spectrum disorders: overview and quality of life issues","volume":"57","author":"Hollander","year":"1996","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2005.04.016_bib18","first-page":"36","article-title":"Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities","volume":"21","author":"Jarry","year":"1996","journal-title":"J. Psychiatry Neurosci."},{"issue":"9","key":"10.1016\/j.euroneuro.2005.04.016_bib19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1176\/ajp.154.9.1261","article-title":"Placebo-controlled trial of fluoxetine and phenylezine for obsessive-compulsive disorder","volume":"154","author":"Jenike","year":"1997","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.euroneuro.2005.04.016_bib20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archpsyc.55.10.927","article-title":"Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa","volume":"55","author":"Kaye","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"issue":"19","key":"10.1016\/j.euroneuro.2005.04.016_bib21","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2005.04.016_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s002130050292","article-title":"CP-94, 253: a selective serotonin 1B (5-HT1B) agonist that promotes satiety","volume":"131","author":"Lee","year":"1997","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.euroneuro.2005.04.016_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF03339985","article-title":"Comorbidity of obsessive compulsive disorder in patients with eating disorders","volume":"3","author":"Lennkh","year":"1998","journal-title":"Eat. Weight Disord."},{"key":"10.1016\/j.euroneuro.2005.04.016_bib24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archpsyc.1997.01830180027004","article-title":"Hormonal and subjective responses to intravenous mCPP in bulimia nervosa","volume":"54","author":"Levitan","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2005.04.016_bib25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0006-3223(01)01201-X","article-title":"Polymorphism of the serotonin 5-HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa","volume":"50","author":"Levitan","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2005.04.016_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0924-977X(03)00063-4","article-title":"Gender in obsessive-compulsive disorder: clinical and genetic findings","volume":"14","author":"Lochner","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2005.04.016_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0010-440X(99)90137-2","article-title":"A comparison of clinical features among Japanese eating-disordered women with obsessive-compulsive disorder","volume":"40","author":"Matsunaga","year":"1999","journal-title":"Compr. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2005.04.016_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00581-1","article-title":"The possible role of 5-HT(1B\/D) receptors in psychiatric disorders and their potential as a target for therapy","volume":"404","author":"Moret","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.euroneuro.2005.04.016_bib29","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1176\/appi.ajp.157.7.1160","article-title":"Is the 5-HT (1Dbeta) receptor gene implicated in the pathogenesis of obsessive compulsive disorder?","volume":"157","author":"Mundo","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2005.04.016_bib30","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.mp.4001059","article-title":"5HT1Dbeta receptor gene implicated in the pathogenesis of obsessive-compulsive disorder: further evidence from a family-based association study","volume":"7","author":"Mundo","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2005.04.016_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1192\/S0007125000291721","article-title":"Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder","author":"Murphy","year":"1989","journal-title":"Br. J. Psychiatr., Suppl."},{"issue":"4","key":"10.1016\/j.euroneuro.2005.04.016_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archpsyc.57.4.358","article-title":"A family study of obsessive-compulsive disorder","volume":"57","author":"Nestadt","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.04.016_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4088\/JCP.v60n0206","article-title":"A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder","volume":"60","author":"Pigott","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2005.04.016_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0006-3223(93)90272-F","article-title":"A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP","volume":"33","author":"Pigott","year":"1993","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2005.04.016_bib35","first-page":"309","article-title":"A preliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive compulsive disorder","volume":"53","author":"Rubenstein","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2005.04.016_bib36","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1176\/ajp.154.8.1120","article-title":"Obsessive-compulsive disorder in the community: an epidemiologic survey with clinical reappraisal","volume":"154","author":"Stein","year":"1997","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2005.04.016_bib37","first-page":"8","article-title":"Compulsive symptoms in anorexia and bulimia nervosa","volume":"45","author":"Thiel","year":"1995","journal-title":"Psychother. Psychosom. Med. Psychol."},{"issue":"11","key":"10.1016\/j.euroneuro.2005.04.016_bib38","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1176\/ajp.156.11.1703","article-title":"Obsessive-compulsive disorder symptoms before and after recovery from bulimia nervosa","volume":"156","author":"von Ranson","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.euroneuro.2005.04.016_bib39","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpsyc.1987.01800230026006","article-title":"Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls","volume":"44","author":"Zohar","year":"1987","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05000830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05000830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T13:31:35Z","timestamp":1706275895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X05000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0924977X05000830"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2005.04.016","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}